Ardelyx, Inc.
ARDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001437402
In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Ardelyx, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 78
- −10 vs. Q1 2022
- Shares held
- 38.0M
- −1.89M (−4.7%) vs. Q1 2022
- Total value
- $22.7M
- −$19.7M (−46.5%) vs. Q1 2022
- New holders
- 22
- 20 more added
- Sold out
- 32
- 21 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 250 | $906.4M |
| Q1 2026 | 242 | $1.01B |
| Q4 2025 | 229 | $972.9M |
| Q3 2025 | 223 | $891.4M |
| Q2 2025 | 206 | $657.3M |
| Q1 2025 | 221 | $808.7M |
| Q4 2024 | 213 | $765.2M |
| Q3 2024 | 203 | $982.8M |
| Q2 2024 | 197 | $1.07B |
| Q1 2024 | 189 | $1.03B |
| Q4 2023 | 161 | $849.0M |
| Q3 2023 | 150 | $513.5M |
| Q2 2023 | 146 | $426.0M |
| Q1 2023 | 130 | $550.1M |
| Q4 2022 | 104 | $225.7M |
| Q3 2022 | 83 | $79.6M |
| Q2 2022 | 78 | $22.7M |
| Q1 2022 | 89 | $42.4M |
| Q4 2021 | 100 | $46.0M |
| Q3 2021 | 108 | $66.7M |
| Q2 2021 | 127 | $643.2M |
| Q1 2021 | 125 | $559.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Ardelyx, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −12,645−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −12,247−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −8,351−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −6,633−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −5,937−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −168−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −256,144−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |